Integrate causally validated target intelligence into early discovery and translational programmes. BiRAGAS provides the mechanistic evidence required to advance candidates with confidence, reduce late-stage attrition, and build the regulatory data packages demanded by the FDA and EMA.

Access platform-grade causal discovery without the infrastructure overhead of building in-house. Biotech partners benefit from the full translational module – discovery through intervention ranking – enabling capital-efficient, evidence-driven target development at any stage of growth.

Advance causal biomedical science through a validated, multi-modal causal inference framework. Academic partners can collaborate on methodology development, validation studies, and joint publications — with academic licensing available for qualifying institutions.

A structured scientific discussion to understand your programme, data assets, research questions, and desired outputs – ensuring the right modules and workflows are configured from the outset.

The platform is configured to your data types, knowledge base requirements, and analytical scope. Proprietary data is integrated securely under a defined data governance framework.

Our scientific team provides support throughout the engagement – from initial interpretation through regulatory preparation – with the option to expand scope as your programme evolves.

Every causal claim is validated across independent evidence streams. No single method, no unchecked assumptions.

Proprietary datasets handled under strict confidentiality protocols with programme-specific isolation.

Findings are suitable for peer-reviewed publication, with full provenance documentation available.

Co-development and IP co-ownership arrangements available for strategic partners contributing novel data or methodology.